Lv3
400 积分 2021-09-20 加入
Brief Report: Safety of Pulse-Dose Osimertinib for Treatment of Leptomeningeal Disease or Refractory Brain Metastases in EGFR-Mutated Nonsmall Cell Lung Cancer
8个月前
已采纳
Brief Report: Safety of Pulse-dose Osimertinib for Treatment of Leptomeningeal Disease or Refractory Brain Metastases in EGFR-mutated Non-small Cell Lung Cancer
8个月前
已采纳
Optimal Sandwich Panel’s Core Design for an Enhanced Impact Resistance
8个月前
已采纳